Skip to main content
Tech.euFundingExplorerBeta

ICG’s Life Sciences

Investor profile

Venture capital

ICG’s Life Sciences has backed 1 European tech company across 1 funding round in 2024, joining rounds totalling €42M. Most active in Healthtech. Data as of Nov 2026.

Deals
1
distinct rounds
Companies
1
backed
Active span
2024
1 yr
Total round €
€42M
sum of rounds joined

Deals by year

distinct rounds / year
ICG’s Life Sciences — deals by year — interactive chart.
Data table
ICG’s Life Sciences — deals by year
20241

Top sectors

by deals
ICG’s Life Sciences — top sectors — interactive chart.
Data table
ICG’s Life Sciences — top sectors
Healthtech1

Stages

by deals
ICG’s Life Sciences — stages — interactive chart.
Data table
ICG’s Life Sciences — stages
Series B1

Countries

by deals
ICG’s Life Sciences — countries — interactive chart.
Data table
ICG’s Life Sciences — countries
UK1

Co-investment network

shared rounds
Co-investment network — interactive chart.
ICG’s Life Sciences — 1 dealsICG’s Life SciencesAndera Partners — 1 shared deals · click to openAndera PartnersBritish Patient Capital — 1 shared deals · click to openBritish Patient CapitalCanaan Partners — 1 shared deals · click to openCanaan PartnersEarlybird Venture Capital — 1 shared deals · click to openEarlybird Venture CapitalOxford Science Enterprises — 1 shared deals · click to openOxford Science EnterprisesPfizer Ventures — 1 shared deals · click to openPfizer Ventures

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Frequent co-investors

shared rounds

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
Grey Wolf TherapeuticsUK1€42M

Biggest deals

top 10 by amount
CompanyStageAmountDate
Grey Wolf TherapeuticsSeries B€42M2024-05
← Back to investors